Organization Profile

You just read:

Aeterna Zentaris' Confirmatory Phase 3 Study for Macrilen™ in AGHD Meets EMA's Study-Design Expectations

News provided by

Aeterna Zentaris Inc.

May 26, 2015, 07:30 ET